Recent Posts
- Lung Cancer [2025] Updates in Treatment & Staging: AACR 9th Edition and Beyond
- Tivozanib for RCC: Unpacking Efficacy, Safety, and Dose Optimization – Bradley McGregor, MD – Dana Farber
- 2025 Breast Cancer Updates: Dr. Evanthia Roussos Torres on Biomarkers, Immunotherapy, and the Future of Treatment – MOASC
- 2025 Leukemia / Lymphoma Updates with Aaron Goodman, MD – UC San Diego – MOASC
- MOASC Awards $25,000 Research Grant from AVEO Oncology to Dr. Peter Zang, MD of City of Hope 2025 Cary Presant, MD Investigator Award
Donate
Oncology Conference Videos
Oncology News
BRCA Carriers Slicing Breast Cancer Odds: Does Surgery Really Lead to Longevity Leaps? Text: @OncoAlert…
Atezolizumab Stumbles in Triple Negative Breast Cancer Study: SABCS 2024 Results with Charles Geyer
We recognize that That combination also made them immunogenic. And so there was always recognition. Over time we came to appreciate that when you see the immune system in there where there’s immune lymphocytes in the tumor, those tumors, those patients seem to do better even in the absence of drug therapy and with drug therapy they do better still.
FGFR2 Mutations and IDH1 Real-World Data Suggests Caution with Immunotherapy in Specific mBTC – ASCO GI Dr. Richard Kim, MD Moffitt Cancer Center
In the rapidly evolving field of cancer treatment, the application of comprehensive genomic profiling (CGP)…
Why isn’t CAR-T Therapy Revolutionizing the Fight Against GI Cancers? 17 Trial Insights from ASCO GI 2025
Introduction:Recent data from the American Society of Clinical Oncology (ASCO) GI Cancers Symposium 2025, as…
EMBER-3 Trial: Pioneering Results in Advanced Breast Cancer TreatmentThe results of the Phase 3 EMBER-3…
Podcast: Phase III KEYNOTE-921 Trial Insights, Brd7 Loss in Lung Metastasis, CDK4 Selective Inhibition Advances, and Children’s Oncology Group Neuroblastoma Mutation Study
Audio Only:Audio, Video and SlidesWhat’s New in Oncology? – Key Updates from Recent ResearchWelcome to…
SABCS 2024
What Are the Latest Melanoma Treatment Advances? [87 Slides] Justin Moyers, MD
…Melanoma treatment has significantly evolved due to extensive research and the introduction of novel therapeutic…